Tenet Healthcare Corporation $THC Shares Sold by Globeflex Capital L P

Globeflex Capital L P trimmed its holdings in Tenet Healthcare Corporation (NYSE:THC) by 25.2% during the first quarter, HoldingsChannel.com reports. The fund owned 36,235 shares of the company’s stock after selling 12,189 shares during the period. Tenet Healthcare makes up approximately 1.0% of Globeflex Capital L P’s holdings, making the stock its 21st largest holding. Globeflex Capital L P’s holdings in Tenet Healthcare were worth $6,838,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of THC. Swedbank AB increased its position in Tenet Healthcare by 14.7% in the 4th quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after acquiring an additional 18,750 shares during the period. Brandywine Global Investment Management LLC lifted its position in Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after acquiring an additional 21,435 shares during the period. M&T Bank Corp increased its holdings in shares of Tenet Healthcare by 1,944.8% in the fourth quarter. M&T Bank Corp now owns 104,304 shares of the company’s stock valued at $20,727,000 after purchasing an additional 99,203 shares during the period. Cerity Partners LLC raised its stake in shares of Tenet Healthcare by 8.4% during the fourth quarter. Cerity Partners LLC now owns 156,141 shares of the company’s stock worth $31,028,000 after purchasing an additional 12,060 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after purchasing an additional 258,956 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on THC. Robert W. Baird dropped their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. KeyCorp cut their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. TD Cowen lowered their price objective on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Finally, Wall Street Zen cut Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, July 18th. Seventeen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $244.84.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC opened at $195.84 on Thursday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The company has a 50-day simple moving average of $184.41 and a 200-day simple moving average of $197.37. The company has a market capitalization of $16.87 billion, a PE ratio of 10.18, a P/E/G ratio of 1.63 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same period in the prior year, the business posted $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts predict that Tenet Healthcare Corporation will post 17.5 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.